Monogenic diabetes

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
A Gastroenterology (ATC A) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
SGLT2 inhibitor 1 substance
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Steno Diabetes Center Copenhagen Academic
    EMPAGLIFLOZIN
    2023-503760-17-00 1 country 2023 n=24
    Ended
  • Steno Diabetes Center Copenhagen Academic
    IMP not specified
    2025-524679-22-00 1 country 2026 n=30
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Steno Diabetes Center Copenhagen Academic 2 Phase II 1
New trials by year
2023
1
2026
1
← All indication landscapes